Advertisement · 728 × 90

Posts by Michael G. Ison, MD MS

Post image

On behalf of the TID section of TTS, ESGICH and the @thetxidjournal.bsky.social we invite you to:

ESGICH – CPC Webinar: Thursday, April 9, 2026, at 14:00 CET

A Neglected Tropical Disease Beyond Endemic Borders: A Case-Based Discussion

Registration link: us06web.zoom.us/webinar/regi...

3 weeks ago 4 0 0 0
Preview
ESGICH ESCMID Global 2027 Session Concept Submission Form Please use this form for ideas for sessions at ESCMID Global 2027. These must be submitted by April 17, 2026 5pm CET so that we can discuss them at our in person/Zoom planning meeting.

Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3...

3/3

4 weeks ago 1 1 0 0
Preview
ESGICH Planning Committee for 2027 ESCMID Global This will be a small working group to help develop proposals for ESGICH to propose for the 2027 ESCMID Global Program. The group will brainstorm in person at ESCMID Global in Munich: Sunday April 1...

Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH...

2/3

4 weeks ago 2 1 1 0

ESGICH is seeking help in developing proposals for
@escmid.bsky.social Global 2027. We are seeking participation in a brainstorming session in Munich April 19 10:30am - 12:30pm in Ostersee Room, 2nd Floor of the ICM. We are also seeking ideas for sessions.

See next tweets w/ details 1/3

4 weeks ago 3 2 1 0
Preview
ESGICH ESCMID Global 2027 Session Concept Submission Form Please use this form for ideas for sessions at ESCMID Global 2027. These must be submitted by April 17, 2026 5pm CET so that we can discuss them at our in person/Zoom planning meeting.

Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3...

3/3

4 weeks ago 1 1 0 0
Preview
ESGICH Planning Committee for 2027 ESCMID Global This will be a small working group to help develop proposals for ESGICH to propose for the 2027 ESCMID Global Program. The group will brainstorm in person at ESCMID Global in Munich: Sunday April 1...

Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH...

2/3

4 weeks ago 2 1 1 0

ESGICH is seeking help in developing proposals for
@escmid.bsky.social Global 2027. We are seeking participation in a brainstorming session in Munich April 19 10:30am - 12:30pm in Ostersee Room, 2nd Floor of the ICM. We are also seeking ideas for sessions.

See next tweets w/ details 1/3

4 weeks ago 3 2 1 0

3 years ago, I was in the Community of Leaders group and can say it had such a huge impact on how I lead - I recommend this to anyone who wants to be a more engaged and effective leader! Time well spent!

1 month ago 0 0 0 0
Advertisement
Post image Post image Post image Post image

First human #H5N1 case of 2026 in #Cambodia: a 30-year-old man from Kampot province. Sequencing, virus isolation & animal investigations ongoing. Dead chicken at home before onset. Patient has since recovered. 🦠💉😷🐓🥼🔬🧪

Sequencing, contact tracing, and poultry investigations ongoing.

2 months ago 15 12 1 0
Preview
Hospital‐Acquired Respiratory Viral Infections (HA‐RVIs) Over 10 Years Disproportionally Affect the Immunocompromised The incidence of HA-Flu/RSV/PIV is associated with patients at high risk of developing RVI complications such as oncology and SCT patients and that most HA cases occur during winter respiratory virus...

Not surprisingly, most adults healthcare-associated respiratory virus infections are immunocompromised and they account for the sickest patients. A key signal to better protect our most vulnerable patients.

onlinelibrary.wiley.com/doi/10.1111/...

2 months ago 4 3 0 1
Preview
Bird flu antibodies found in cow in the Netherlands, a first outside of U.S. Dead cat led to discovery, but officials stress no further spread of H5N1 has been detected

www.science.org/content/arti...

2 months ago 12 12 0 1

But worth it for piece of mind.

4 months ago 2 0 0 0

It’s actually hard to get the vaccine - we got ours but it required pre-paying for the doses and having delays in getting them delivered to the pharmacy. Total cost $900 with GoodRx and 3 doses so takes time. Doable but expensive and takes a lot of effort to arrange (in my experience).

4 months ago 3 0 1 0
Preview
Hospital‐Acquired Respiratory Viral Infections (HA‐RVIs) over 10 Years Disproportionally Affect the Immunocompromised The incidence of HA-Flu/RSV/PIV is associated with patients at high risk of developing RVI complications such as oncology and SCT patients and that most HA cases occur during winter respiratory virus...

So happy to see this paper out after a lot of persistence from Shardul Rathod @hannahnam.bsky.social @ucirvine.bsky.social.

Over a 10 yr period, 6.6% of Flu cases, 12.2% of RSV cases, and 10.9% of PIV cases were Hosp-Acquired. Most in ICH.

onlinelibrary.wiley.com/doi/10.1111/...

4 months ago 6 1 0 0
Post image

I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social

5 months ago 12 2 1 0
Preview
Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Herpes Simplex Virus-infected Patients in Phase 3 Pivotal Trial - Aicuris Aicuris today announced that the Phase 3 trial of its lead candidate pritelivir has met its primary and secondary endpoint. The aim of the trail was to evaluate

Important Ongoing Studies where we have or will have publications soon:

Pritelivir for refractory or resistant HSV (presented @idweek.bsky.social by @kottonnelson.bsky.social): www.aicuris.com/press-releas...

CD388 for prevention of influenza: www.cidara.com/news/cidara-...

5 months ago 6 2 0 0
Advertisement
Preview
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSV... A single RSVPreF3 OA dose was efficacious against RSV-LRTD over three RSV seasons in people aged 60 years or older, despite a decrease in efficacy over time. Further research is needed to establish th...

Results from season 3 of the GSK RSV Vaccine (NOTE - I was the lead author so I’m biased on this one)
www.thelancet.com/journals/lan...

Two trials on tecovirimat for Mpox and the need to consider research in context of EUA medications
www.nejm.org/doi/full/10....
evidence.nejm.org/doi/full/10....

5 months ago 4 2 1 0
Preview
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | NEJM Baloxavir marboxil (baloxavir) rapidly reduces influenza virus shedding, which suggests that it may reduce transmission. Studies of treatment with neuraminidase inhibitors have not shown sufficient...

Study of baloxavir to prevent household transmission of influenza
www.nejm.org/doi/full/10....

Two studies of monoclonals for RSV prevention
www.nejm.org/doi/full/10....
www.thelancet.com/journals/lan...

5 months ago 2 1 1 0
Preview
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons | NEJM Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of human immunodeficiency virus (HIV) infection in cisgender women. The efficacy of lenacapavir for preexposure...

Two trials on lenacapravir for prevention of HIV
www.nejm.org/doi/full/10....
www.nejm.org/doi/10.1056/...

Two trials on high dose influenza vaccine
jamanetwork.com/journals/jam...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/abs/10.1...

5 months ago 5 2 1 0

Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:

See next posts

5 months ago 35 14 5 2

Thanks to Lara Danziger-Isakov for doing the talk.

Slides:
www.dropbox.com/scl/fi/nj1z8...

5 months ago 5 0 0 0

Due to the US Government Shutdown, I will not be able to atted @IDWeek.bsky.social #IDWeek2025. I had worked on my 2 invited talks and so will share them.

My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.

5 months ago 13 2 1 0
Preview
Influenza Antivirals for Prevention and Treatment in Immunocompromised People Antivirals are an important backbone for the prevention and treatment of influenza in immunocompromised individuals, who are prone to prolonged viral shedd

Included in the supplement is an important paper about application of antivirals in immunocompromised patients @mady247.bsky.social

academic.oup.com/jid/article/...

6 months ago 3 1 0 0
Preview
Volume 232 Issue Supplement_3 | The Journal of Infectious Diseases | Oxford Academic An official journal of the Infectious Diseases Society of America. Publishes research results on microbiology, immunology, and epidemiology; pathogenesis, diagnosis, and treatment of infectious diseas...

Excited to see the “Advances in Influenza Therapeutics” supplement out in @jidjournal.bsky.social - led by Fred Hayden and Rich Whitley, this supplement reviews what we know about antivirals and how they should be used for influenza.

academic.oup.com/jid/issue/23...

6 months ago 5 3 1 0

Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!

6 months ago 8 1 1 0
Advertisement
Redirecting

check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with
@michaelisonmd.bsky.social
on this! #TxID doi.org/10.1016/j.jh...

7 months ago 4 1 0 0
Post image

The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.

7 months ago 6 0 2 0
Preview
Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation Lung transplantation (lung-tx) offers the last life-saving option for patients with COVID-19-associated lung injury (CALI). We show that the RBD-speci…

Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses.

www.sciencedirect.com/science/arti...

8 months ago 3 1 0 0
Post image

AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate.

ajt-transplant-id-exchange.squarespace.com

9 months ago 9 8 0 1
Preview
AJT Transplant ID Exchange

Don't miss the new @amjtransplant.bsky.social #TxID blog led by Emily Blumberg ajt-transplant-id-exchange.squarespace.com #wtc2025 @ast-idcop.bsky.social @ast-tyfcop.bsky.social @astinfo.bsky.social

8 months ago 13 6 0 0